{"doi":"10.1007/s11884-025-00775-9","title":"New Imaging Techniques on the Horizon to Study Overactive and Neurogenic Bladder","abstract":"Purpose of Review: This review will focus on the current usage and the potential future applications of new imaging techniques on the horizon to study overactive and neurogenic bladder. Recent Findings: Bladder Near-Infrared Spectroscopy (NIRS) has been used to non-invasively identify bladder outlet obstruction, detrusor overactivity, and other forms of voiding dysfunction, but motion artifact has been a limiting factor preventing widespread adaptation. However, newer NIRS units employ accelerometers which enable isolation and splicing of motion and on-going studies show renewed promise for bladder NIRS. Ultrasound has been successfully used to evaluate bladder outlet obstruction and other forms of LUT. Techniques including m-mode evaluation of micromotion, as well as the assessment of bladder wall thickness, bladder weight, shape/circularity, vibrometry, and elastography have been explored. Dynamic bladder functional magnetic resonance imaging (fMRI) is the newest bladder imaging technology on the horizon and provides a novel method to assess bladder function alongside real-time high-resolution 3D anatomic images. Summary: Bladder imaging techniques including NIRS, ultrasound, and functional fMRI have been developed and are now being used as noninvasive techniques that could potentially supplement, or even replace, traditional Urodynamics.","journal":"Current Bladder Dysfunction Reports","year":2025,"id":538069,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":4,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9561,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1424715,"name":"Ethan S. Casto","orcid":null,"position":1,"is_corresponding":false},{"id":698226,"name":"Linda S. Burkett","orcid":"0000-0003-2228-9223","position":2,"is_corresponding":false},{"id":791265,"name":"John E. Speich","orcid":"0000-0002-8824-4098","position":3,"is_corresponding":false},{"id":388087,"name":"Alejandro Roldán‐Alzate","orcid":"0000-0003-4149-4038","position":4,"is_corresponding":false},{"id":791266,"name":"Adam P. Klausner","orcid":"0000-0003-3849-7131","position":5,"is_corresponding":false},{"id":1424714,"name":"Nyasia Jones","orcid":null,"position":0,"is_corresponding":true}],"reference_count":66,"raw_metadata":null,"created_at":"2026-07-19T02:52:16.891390Z","pmid":"40062201","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}